The Discounted Cash Flow (DCF) valuation of Castle Biosciences Inc (CSTL) is 10.32 USD. With the latest stock price at 20.42 USD, the upside of Castle Biosciences Inc based on DCF is -49.5%.
Based on the latest price of 20.42 USD and our DCF valuation, Castle Biosciences Inc (CSTL) is a sell. selling CSTL stocks now will result in a potential gain of 49.5%.
| Range | Selected | |
| WACC / Discount Rate | 6.0% - 7.9% | 6.9% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 7.18 - 25.53 | 10.32 |
| Upside | -64.8% - 25.0% | -49.5% |